ACAD

ACADIA Pharmaceuticals Inc.

Contracts

Total Value

Stock Metrics

8.5%

Short % Float

8.0d to cover · Moderate squeeze

97.8%

Inst % Float

10 holders · 2026-06-30

Baker Bros. Adviso

Top Holder

24.9% of float

127.3M sh

Public Float

12/100

Dilution Score

Low

24+ mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

12/100

LOW

Inst: 97.78% · Top: Baker Bros. Advisors, LP

Biotech Analytics

Neuroscience

53.13

Squeeze risk: MODERATE

Insider Buying0

Publications100

Dilution Risk12

Clinical Trials100

Short Interest30